主催: The Japanese Pharmacological Society, The Japanese Society of Clinical Pharmacology
会議名: WCP2018 (18th World Congress of Basic and Clinical Pharmacology)
開催地: Kyoto
開催日: 2018/07/01 - 2018/07/06
Non-small cell lung cancer (NSCLC) accounts for about 85% of the total amount of lung cancer. Chemotherapy is the major treatment for it, but accompanied by many adverse reactions and side effects. In recent years, the combination of traditional Chinese medicine and chemotherapy researches revealed that traditional Chinese medicine in the process of chemotherapy produced an effective synergistic attenuated effect, especially outstanding in the therapy of lung cancer. This paper summarized the experimental studies of traditional Chinese medicine combined with chemotherapy for the treatment of non-small cell lung cancer. The combination therapy mainly displayed the efficacy in five aspects: inhibiting the growth of tumor cell and promoting apoptosis, reversing tumor drug resistance and sensitizing effect, enhancing immunity, improving curative effect, reducing side effects and adverse reactions. The series of research results showed that traditional Chinese medicine combined with chemotherapy for the treatment of non-small cell lung cancer has a significant effect, as well as a wide range of clinical applications.